Actively Recruiting
Statins for Treatment of Primary Intracerebral Hemorrhage
Led by The Second Hospital of Anhui Medical University · Updated on 2025-07-28
264
Participants Needed
22
Research Sites
190 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The STOP ICH trial is a multicenter, prospective, randomized, open-label, blinded end-point (PROBE) study designed to assess the efficacy and safety of atorvastatin in patients with intracerebral hemorrhage (ICH) presenting within 3 to 24 hours of symptom onset.
CONDITIONS
Official Title
Statins for Treatment of Primary Intracerebral Hemorrhage
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of spontaneous intracerebral hemorrhage confirmed by CT scan
- Age between 18 and 80 years
- Hematoma located in the supratentorial region
- Time from symptom onset or last known well to baseline CT between 3 and 24 hours
- Atorvastatin treatment can start within 48 hours of symptom onset or last known well
- Glasgow Coma Scale score of 9 or higher
- Baseline hematoma volume between 5 and 35 mL
- Signed informed consent obtained
You will not qualify if you...
- Intracerebral hemorrhage caused by trauma, tumor, aneurysm, arteriovenous malformation, vascular anomaly, hemorrhagic transformation of infarction, cerebral venous thrombosis, or related to anticoagulant use
- Patients who have had or are planned for immediate surgical intervention
- Pregnancy or breastfeeding
- Use of oral anticoagulants within 1 month before symptom onset
- Pre-stroke modified Rankin Scale score greater than 1
- Known allergy to statins, active liver disease, liver dysfunction, or rhabdomyolysis
- Terminal illness with life expectancy under three months or planned withdrawal of care
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 22 locations
1
Anqing First People's Hospital of Anhui Province
Anqing, Anhui, China
Actively Recruiting
2
Fuyang City Sixth People's Hospital
Fuyang, Anhui, China
Actively Recruiting
3
Fuyang Hospital of Anhui Medical University
Fuyang, Anhui, China
Actively Recruiting
4
Fuyang People's Hospital
Fuyang, Anhui, China
Actively Recruiting
5
Hefei Eighth People's Hospital
Hefei, Anhui, China
Actively Recruiting
6
Hefei First People's Hospital
Hefei, Anhui, China
Actively Recruiting
7
The Second Hospital of Anhui Medical University
Hefei, Anhui, China
Actively Recruiting
8
Huainan Xinhua Hospital
Huainan, Anhui, China
Actively Recruiting
9
The First Affiliated Hospital of Anhui University of Science and Technology (Huainan First People's Hospital)
Huainan, Anhui, China
Actively Recruiting
10
Huoqiu First People's Hospital
Lu'an, Anhui, China
Actively Recruiting
11
Shucheng People's Hospital
Lu'an, Anhui, China
Actively Recruiting
12
Si County People's Hospital
Suzhou, Anhui, China
Actively Recruiting
13
The First Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Actively Recruiting
14
Kaifeng Central Hospital
Kaifeng, Henan, China
Actively Recruiting
15
Xihua County People's Hospital
Zhoukou, Henan, China
Actively Recruiting
16
Xiangyang Hospital of Traditional Chinese Medicine
Xiangyang, Hubei, China
Actively Recruiting
17
The First People's Hospital of Chenzhou
Chenzhou, Hunan, China
Actively Recruiting
18
Yancheng First People's Hospital
Yancheng, Jiangsu, China
Actively Recruiting
19
Chengdu Western Hospital
Chengdu, Sichuan, China
Actively Recruiting
20
Panzhihua Central Hospital
Panzhihua, Sichuan, China
Actively Recruiting
21
Dazhu County People's Hospital
Dazhou, Sizhuan, China
Actively Recruiting
22
The Third Affiliated Hospital of Chong Qing Medical University
Chongqing, China
Actively Recruiting
Research Team
Q
Qi Li
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here